No dosage adjustment of ZEPBOUND is recommended for patients with renal impairment
Any concerning symptoms following alcohol consumptionincluding severe nausea, persistent vomiting, signs of dehydration, or symptoms suggestive of pancreatitis or gallbladder diseasewarrant prompt medical evaluation and discontinuation of tirzepatide until assessed by a healthcare provider
Tirzepatide may be appropriate for individuals who: Have a BMI of 30 or higher (obesity), or 27 or higher with a weight-related health condition such as hypertension, type 2 diabetes, or dyslipidemia Have not achieved adequate results through diet and exercise alone Have pre-diabetes and need improved blood sugar control and weight management Are committed to ongoing medical supervision and lifestyle support throughout treatment Tirzepatide is not appropriate for individuals who: Have a personal or family history of medullary thyroid carcinoma Are pregnant or planning to become pregnant Have a known hypersensitivity reaction to tirzepatide or its ingredients Have a history of confirmed pancreatitis (discuss with provider) If you are considering tirzepatide and want a comprehensive assessment of whether it is appropriate for your specific health profile, TRT Nations Medical Weight Loss Assessment is a clinically guided starting point designed to help patients and providers align on the right treatment approach
Antiemetics : Antiemetics is used to relieve nausea and vomiting
The results showed that tirzepatide, at all doses, achieved superior reductions in HbA1c compared to insulin degludec at week 52, meeting the non-inferiority criteria
